NexGel, Inc. (NXGL)
0.6851
-0.09
(-12.01%)
USD |
NASDAQ |
Mar 20, 16:00
0.682
0.00 (0.00%)
After-Hours: 20:00
NexGel Research and Development Expense (Quarterly) : 0.007M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| The Cooper Cos., Inc. | 44.30M |
| STAAR Surgical Co. | 9.042M |
| OrthoPediatrics Corp. | 2.259M |
| Innovative Eyewear, Inc. | 0.13M |
| Plus Therapeutics, Inc. | 2.941M |